Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-03 09:38:41 - browse：25169

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Takeda, Janssen join wearable maker to measure scratching

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Despite FDA concern, risk that CAR

The EPA's new lead rule: How one expert crunched the numbers

Readout Newsletter: Beam, Prozac, "TechBio" and more

focus

Wikipedia

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Using force crossed my mind when examining a defiant young patient

Affirmative action in medical school literally saved lives

U.K. Biobank has 500,000 peoples' genome sequences available

The cancer drug shortage isn’t new — and neither are the solutions

Flagship Pioneering launches a new biotech in two countries

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The EPA's new lead rule: How one expert crunched the numbers

Continuity nursing helped my family in our darkest PICU moments

J&J to emphasize cancer drugs, stop much of its vaccine research

knowledge

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

With clinical trial data readouts, here's how to spot spin

Takeda, Janssen join wearable maker to measure scratching

CDC panel: People 65 and older should get a Covid spring booster shot

entertainment

focus

hotspot

Wikipedia